Medindia

X

Reportlinker Adds Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED

Friday, August 20, 2010 General News J E 4
Advertisement


NEW YORK, Aug. 19 Reportlinker.com announces that a new market research report is available in its catalogue:

Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED

http://www.reportlinker.com/p0265199/Advances-in-Large-Scale-BioManufacturing-and-Scale-Up-Production-2nd-ED.html

A Comprehensive Study of the Science, Technology and Business of Biopharmaceutical Manufacturing. This new ASM study provides a clear view of what the industry perceives to be the future of biopharmaceutical manufacturing.

Chapter Abstracts Index:

Frontiers in Bioprocessing: 2007

The Science for Biogenerics: Are We There Already?

Maximizing Productivity in Biopharmaceutical Manufacturing

Increasing Performance of Mammalian Expression Platforms

Cell Line Engineering and Development: Case Studies

Design of Large-Scale Cell Culture Process

Challenges in Biopharmaceutical Scale-up to Production

Large-Scale Microbial Production Technology for Human Therapeutic Products

Microbiological Methods in Support of Manufacturing

Initial Protein Recovery Process

The Scaling Up of Fermentation and Primary Recovery Processes of Soluble Protein Antigens

Scale-up of Saccharomyces cerevisiae Fermentation

Good Automation Manufacturing Practice (GAMP)

Advances in Improved Expression of Recombinant Proteins in Microbial Systems

Design of Large-Scale Cell Culture Process --A Process Engineering Point of View

Protein Stability, Solubility and Solute Interactions

Launching New Biologics: A Process and Facility Design Approach

Disposable Technologies for Manufacturing of Biologics

Managing Large Volume, Single Use Disposables

Optimization of Antibody Processing: Upstream and Downstream

Simulated Moving Bed Chromatography

Implementation of Membrane Technology in Antibody Large-Scale Purification

Development of Viral Clearance Strategies for Large-Scale Monoclonal Antibody Production

Downstream Processing: Removing Economic and Technical Bottlenecks

Purification of Monoclonal and Genetically Engineered Antibodies

Regulatory Environment for Follow-on Biologics

Post-Approval Changes for Large Scale Biopharmaceutical Manufacturing: Global

FDA and Regulatory Issues in Biopharmaceutical Manufacturing

Strategic Issues: Capital Investments

Pricing Issues for Biotechnology Products

Economics of Scheduling, De-bottlenecking, and Cycle Time

Intellectual Property Considerations in Scale-Up of Biomanufacturing Processes

Forecasting Industry-wide Biopharmaceutical Manufacturing Capacity Requirements

Worldwide Therapeutic Protein Production Capacity

Authors and Reviewers:

Accelsiors Group International

Advanced Scientifics Inc.

Amgen, Inc.

Amgen, Inc.

Amgen, Inc.

Amgen, Inc.

Amgen, Inc.

Biogen IDEC

Biomanufacturing Training and Education Center

BioPharm Services UK

BioProcess Technology

Biotechnology Unit, NIDDK, NIH

Bristol Myers Squibb

Chromos, Burnaby, BC

Cambrex Bio Science

Clonex Development, Inc.

Consultants Inc.

Eli Lilly & Co.

Eli Lilly & Co.

Eli Lilly & Co.

Eli Lilly & Co.

Falconridge Associates

Fluor Corporation/Fluor Daniel Inc.

Fluor Corporation/Fluor Daniel Inc.

Fluor Corporation/Fluor Daniel Inc.

GE Healthcare

Human Genome Sciences

Institute for Chemical and Bioengineering

Intelligen, Inc.

Johns Hopkins University

Magneticals

Max Planck Institute

Medical Marketing Economics, LLC

Medimmune

Merck & Co., Inc.

Merck Research Laboratories

Merck Research Laboratories

Morphotek

NC State University

ncBIOsource

Newport Biotech Consultants

Newport Consulting

Novavax Inc

Novozymes Delta Limited

PD-Direct Services

Protein Sciences Corp

SAIC, National Cancer Institute

Sanofi Pasteur

Sartorius AG, Germany

Schwegman Lundberg Woessner & Kluth

Scios Inc.

Seattle Genetics

Strategic Manufacturing Worldwide, Inc.

TLG Consulting Inc.

Universite Clermont

Vectech Pharmaceutical Consultants, Inc.

To order this report:

Biopharmaceutical Industry: Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED

Biopharmaceutical Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Contact Nicolas Bombourg: nbo@reportlinker.com US: (805)-652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Leaders to Discuss Future of Healthcare and Techno...
S
Heritage Provider Network, Regal Medical Group and...